Budget impact analysis of sarilumab for the treatment of...

Budget impact analysis of sarilumab for the treatment of rheumatoid arthritis in patients with an inadequate response to conventional synthetic DMARD or TNF inhibitor therapies

Ferrufino, Cheryl P, Munakata, Julie, Wei, Wenhui, Proudfoot, Clare, Kuznik, Andreas, Boklage, Susan H, Chen, Chieh-I
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
Volume 10
Language:
english
Journal:
ClinicoEconomics and Outcomes Research
DOI:
10.2147/CEOR.S163829
Date:
November, 2018
File:
PDF, 511 KB
english, 2018
Conversion to is in progress
Conversion to is failed